All Articles and Material should be submitted on-line via EES - http://ees.elsevier.com/lr/ . Please refer to the 'Tutorial for Authors' located on the EES site for guidance on the electronic submission process.
If you are unable to submit online or have any general queries, please contact the Editorial Offices regarding alternatives:
Professor
Terry Hamblin
Royal Bournemouth Hospital
Castle Lane East
Bournemouth BH7 7DW
UK
Ellin Berman, Memorial
Sloan Kettering Cancer Center, 1275 New York Avenue, New York, NY 10021, USA
Tel: +1 212 639 7762
Fax: +1 212 794 4338
Types
of Contribution Original Articles usually do not exceed 10 to 12 pages of text but longer papers may be considered if
relevant. Original full-length research papers which have not been published previously, except in a preliminary form, may be submitted
as regular papers. Original articles reporting on clinical trials must conform to the guidelines of the Working Group on Recommendations
for Reporting of Clinical Trials (Table 1).
Reviews and Editorials should be submitted after prior consultation with the
Editors.
Brief Communications and Preliminary Reports should not exceed 5 pages of text, 4 illustrations and 8 references.
Letters to LEUKEMIA RESEARCH should clearly indicate the purpose of the letter by a brief striking title and should not
exceed 2 pages of typescript.
Comments on Published Papers like "Letters to LEUKEMIA RESEARCH" but also mentioning the title
of the paper to which it is addressed.
Cases of the Month should not exceed 5 pages of typescript.
Congress Letters
are free reports on one or several sessions of Congress, Workshops or Symposia (also closed ones), signed by the author(s) whose name
appears in the List of Contents. Indicate complete information on the meeting covered, including programme.
Open Forum concerns
hypotheses, models or experiments which authors wish to see performed but cannot perform themselves. Comments made under this heading
engage only the authors and not the Journal, and publication will be at the discretion of the Editors.
Submission of an article implies
that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic
thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or
explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in
the same form, in English or in any other language, without the written consent of the Publisher.
Role of corresponding author
The corresponding author of a manuscript for Leukemia Research has the duty to ensure that all the named authors have seen and
approved the original and any revised version of the paper and are in agreement with its content before it is submitted to the Editorial
Office. Each author should have participated sufficiently in the work to take public responsibility for the content. The corresponding
author should also ensure that all those who have contributed to the research are acknowledged appropriately either as a co-author or
in the Acknowledgements. In addition, the corresponding author has the prime responsibility for ensuring the paper is correctly prepared
according to the Guide for Authors. Submitted manuscripts not complying with the Guide for Authors may be returned to the authors for
possible revision and resubmission.
Upon acceptance of an article, authors will be asked to transfer copyright (for more information
on copyright see http://ees.elsevier.com/lr/). This transfer will ensure the widest possible dissemination of information.
A letter will be sent to the corresponding author confirming receipt of the manuscript. A form facilitating transfer of copyright will
be provided. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners
and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: contact ELSEVIER, Global Rights
Department, P.O. Box 800, Oxford, OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail: permissions@elsevier.com
When submitting by post, three (3) hardcopies are required. Be very careful to follow the style for headings, references, key words
and other matters as seen in a recent issue of the journal. Please supply FAX and E-mail addresses if available.
All manuscripts
are peer-reviewed. On receipt of the first decision letter authors should send their revised manuscript within three months in order
to ensure that the scientific content of their manuscript is timely and up to date.
Preparation of manuscripts
1. The
Chief Editors request that papers submitted for publication should be written concisely and clearly. Manuscripts should be written in
English. Authors whose native language is not English are strongly advised to have their manuscripts checked by an English-speaking colleague
prior to submission. Either the Concise Oxford Dictionary or Webster's New International Dictionary may be used as a standard for English
spelling.
Authors in Japan please note:
Upon request, Elsevier Japan will provide authors with a list of people who
can check and improve the English of their paper (before submission). Please contact our Tokyo office:
Elsevier Japan
9-15, Higashi-Azabu
1-chome
Minato-ku, Tokyo 106-0044
Japan
Tel. (+81) 3-5561-5032
Fax: (+81)3-5561-5045
E-mail: info@elsevier.co.jp
2. Manuscripts should be organised in the following sequence:
Cover page (see above)
Abstract
Keywords
Introduction
Materials and methods
Results
Discussion (including Conclusions)
Acknowledgments and any additional information concerning
research grants, etc.
References
Tables
Figure captions
3. In typing the manuscript, titles and subtitles should not
be run within the text. They should be typed on a separate line, without indentation. Use lower-case letter type. First and second order
headings should be numbered.
4. SI units should be used, but authors may include conversions for unfamiliar units (1 bar=0.1 MPa).
Do not include periods. Note the following conventions: e.g. not eg., rev min-1 not rpm, mg kg-1 or l-1
not ppm, 1 bar equals 0.1 MPa, round off units to eliminate unnecessary decimal places, e.g. 124 mu not 0.124 mm (note space between
number and unit), l not L for litre, kg not Kg, s not sec, min not mins, h not hr, d for day, y not yr, 25 t ha-1 not 25 tonnes/ha,
3 mg cm-3 not three mg per cubic cm, 23?C and 23% (no spaces), (Keating et al., 1996) not (Keating et al., 1996), al. is an
abbreviation of alii (others - Latin). Molar concentrations should appear in small caps.
5. Abbreviations may be used for unwieldy
names which occur frequently and such abbreviations must be defined the first time they occur in the text. Conventional abbreviations,
e.g. EDTA, ATP, 2,4-D should be used in preference to freshly coined ones.
6. Elsevier reserves the privilege of returning to the
author for revision accepted manuscripts and illustrations which are not in the proper form given in this guide. On arrival at the Editorial
Office, papers will be checked to determine if they conform to the style and format for Leukemia Research. Papers that do not
comply may be returned to the corresponding author with a check list detailing faults and omissions.
7. Avoid new or uncommon acronyms.
Use single letters (Greek, Roman, italic) for variables with subscripts as appropriate.
Title
This should be clear, descriptive
and brief. Avoid non-specific phrases such as "A study of..." or "The effects of...". Do not give the title a numbered subtitle or series
number.
Abstract
The abstract should be clear, descriptive and not longer than 100 words.
Keywords
Keywords
are index terms or descriptions for information retrieval systems, normally 6 to 8 items. Words selected should reflect the essential
topics of the article and may be taken from both the title and the text.
Introduction
This should give the reasons for
doing the work. As this is a specialist journal a detailed review of the literature is not necessary. The Introduction should preferably
conclude with a final paragraph stating concisely and clearly the Aims and Objectives of the investigation.
Materials and methods
A full technical description of a method should be given in detail only when the method is new.
Results
This need only
report results of representative experiments illustrated by Tables and Figures. Use well-known statistical tests in preference to obscure
ones. Consult a statistician or a statistics text for detailed advice.
Discussion
This section must not recapitulate results
but should relate the authors' experiments to other work and give their conclusions, which may be given in a subsection headed Conclusions.
Acknowledgments
Do not include grant numbers or institutional journal publication numbers. All papers must include an
acknowledgements section that details financial support and any conflicts of interest.
An example of an acknowledgement section follows
below:
This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology
of Japan (No.14570180).
Tables
1. Authors should take notice of the limitations set by the size and lay-out of the journal.
Large tables should be avoided. Reversing columns and rows will often reduce the dimensions of a table.
2. If many data are to be
presented, an attempt should be made to divide them over two or more tables.
3. Drawn tables, from which blocks need to be made,
should not be folded.
4. Tables should be numbered according to their sequence in the text. The text should include references to
all tables.
5. Each table should be typewritten on a separate page of the manuscript. Tables should never be included in the text.
6. Tables and their footnotes should be typed using a readable uniform font of the same size as that used in the text. Each text
should have a brief and self-explanatory title.
7. Column headings should be brief, but sufficiently explanatory. Standard abbreviations
of units of measurement should be added between parentheses.
8. Vertical lines should not be used to separate columns. Leave some
extra space between the columns instead.
9. Any explanation essential to the understanding of the table should be given as a footnote
at the bottom of the table.
10. Zero results must be represented by 0 and no determination by ND; the dash sign (-) is ambiguous.
Report data in such a way that readers can assess the degree of experimental variation and estimate the variability or precision of the
findings. Use the standard deviation SD and the mean to summarise data and to show the variability among individuals. Use the standard
error of the mean SEM to show the precision of the sample mean. Always state the number of measurements on which means are based. In
tables and figures use asterisks to indicate probability values (P). In footnotes or text show the degree of significance of P, e.g.
P <0.05*.
Preparation of electronic illustrations
Submitting your artwork in an electronic format helps us to produce
your work to the best possible standards, ensuring accuracy, clarity and a high level of detail.
• Always supply high-quality
printouts of your artwork, in case conversion of the electronic artwork is problematic. • Make sure you use uniform lettering
and sizing of your original artwork. • Save text in illustrations as "graphics" or enclose the font. • Only use the
following fonts in your illustrations: Arial, Courier, Helvetica, Times, Symbol. • Number the illustrations according to their
sequence in the text. • Use a logical naming convention for your artwork files, and supply a separate listing of the files and
the software used. • Provide all illustrations as separate files and as hardcopy printouts on separate sheets. • Provide
captions to illustrations separately. • Produce images near to the desired size of the printed version.
Files can be stored
on 3? inch diskette, ZIP-disk or CD (either MS-DOS or Macintosh).
If you are unable to submit your files in an electronic format, then please adhere
to the following instructions:
1. All illustrations (line drawings and photographs) should be submitted separately, unmounted
and not folded. They should be camera ready. Proportion figure and tables to fit 75-mm or 160-mm column widths.
2. Illustrations
should be numbered according to their sequence in the text. References should be made in the text to each illustration.
3. Each
illustration should be identified on the reverse side (or - in the case of line drawings - on the lower front side) by its number and
the name of the author. An indication of the top of the illustrations is required in photographs of profiles, thin sections, and other
cases where doubt can arise.
4. Illustrations should be designed with the format of the page of the journal in mind. Illustrations
should be of such a size as to allow a reduction of 50%.
5. Lettering should be in black ink or by printed labels. Make sure that
the size of the lettering is big enough to allow a reduction of 50% without becoming illegible. The lettering should be in English. Use
the same kind of lettering throughout in a sans serif typeface (e.g. Helvetica, Arial, Univers, Swiss etc.)
6. If a scale should
be given, use bar scales on all illustrations instead of numerical scales that must be changed with reduction.
7. Each illustration
should have a caption. The captions to all illustrations should be typed in sequence on a separate sheet of the manuscript.
8. Explanations
should be given in the typewritten legend. Drawn text in the illustrations should be kept to a minimum.
9. Photographs are only
acceptable if they have good contrast and intensity. Sharp and glossy copies are required. Reproductions of photographs already printed
cannot be accepted.
You are urged to visit this site; some excerpts from the detailed information are given here.
Formats
Regardless of the application used, when your electronic artwork is finalised, please "save as" or convert the images to one
of the following formats (Note the resolution requirements for line drawings, halftones, and line/halftone combinations given below.):
EPS: Vector drawings. Embed the font or save the text as "graphics".
TIFF: Colour or greyscale photographs (halftones): always
use a minimum of 300 dpi.
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone
(colour or greyscale): a minimum of 500 dpi is required.
DOC, XLS or PPT: If your electronic artwork is created in any of these Microsoft
Office applications please supply "as is".
Please do not: • Supply embedded graphics in your wordprocessor (spreadsheet,
presentation) document; • Supply files that are optimised for screen use (like GIF, BMP, PICT, WPG); the resolution is too low;
• Supply files that are too low in resolution; • Submit graphics that are disproportionately large for the content.
Colour reproduction
Submit colour illustrations as original photographs, high-quality computer prints or transparencies,
close to the size expected in publication, or as 35 mm slides. Polaroid colour prints are not suitable. If, together with your accepted
article, you submit usable colour figures then Elsevier will ensure, at no additional charge, that these figures will appear in colour
on the web (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in colour in the printed
version. For colour reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted
article. For further information on the preparation of electronic artwork, please see http://ees.elsevier.com/lr/.
Please
note: Because of technical complications which can arise by converting colour figures to 'grey scale' (for the printed version should
you not opt for colour in print) please submit in addition usable black and white prints corresponding to all the colour illustrations.
References
All publications cited in the text should be presented in a list of references following the text of the manuscript.
In the text refer to references by a number in square brackets on the line (e.g. Since Peterson[1]), and the full reference should be
given in a numerical list at the end of the paper.
References should be given in the following form:
1. Latagliata R, Concetta Petti
M, Mandelli F. Acute myeloid leukemia in the elderly: 'per aspera ad astra'? Leukemia Res 1999;23:603-613.
2. Alfrey V. The isolation
of subcellular components. In: Brachet J, Mirsky AE, editors. The cell, biochemistry, physiology, morphology I. New York: Academic Press,
1959. p. 200.
Note: Authors are strongly encouraged to check the accuracy of each reference against its original source.
In the case of publications in any language other than English, the original title is to be retained. However, the titles of publications
in non-Roman alphabets should be transliterated, and a notation such as "(in Russian)" or "(in Greek, with English abstract)" should
be added.
Work accepted for publication but not yet published should be referred to as "in press". Authors should provide evidence
(such as a copy of the letter of acceptance).
References concerning unpublished data, theses, and "personal communications" should
not be cited in the reference list but may be mentioned in the text.
Formulae
1. Formulae should be typewritten, if possible.
Leave ample space around the formulae.
2. Subscripts and superscripts should be clear.
3. Greek letters and other non-Roman
or handwritten symbols should be explained in the margin where they are first used. Take special care to show clearly the difference
between zero (0) and the letter O, and between one (1) and the letter l.
4. Give the meaning of all symbols immediately after the
equation in which they are first used.
5. For simple fractions use the solidus (/) instead of a horizontal line.
6. Equations
should be numbered serially at the right-hand side in parentheses. In general only equations explicitly referred to in the text need
be numbered.
7. The use of fractional powers instead of root signs is recommended. Also powers of e are often more conveniently
denoted by exp.
8. Levels of statistical significance which can be mentioned without further explanation are *P <0.05, * *P <0.01 and * * *P <0.001.
9. In chemical formulae, valence of ions should be given as, e.g., Ca2+,
not as Ca++.
10. Isotope numbers should precede the symbols, e.g., 18O.
Footnotes
Footnotes should only be used to provide addresses of authors or to provide explanations essential to the understanding of Tables.
Supplementary data
Elsevier now accepts electronic supplementary material to support and enhance your scientific research.
Supplementary files offer the author additional possibilities to publish supporting applications, movies, animation sequences, high-resolution
images, background datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic version
of your article in Elsevier web products, including ScienceDirect: http://www.sciencedirect.com. In order to ensure that
your submitted material is directly usable, please ensure that data is provided in one of our recommended file formats. Authors should
submit the material in electronic format together with the article and supply a concise and descriptive caption for each file. For more
detailed instructions please visit: http://ees.elsevier.com/lr/.
Enquiries
Authors can keep a track on the
progress of their accepted article, and set up e-mail alerts informing them of changes to their manuscript's status, by using the "Track
a Paper" feature at:http://www.elsevier.com/trackarticle. For privacy, information on each article is password-protected.
The author should key in the "Our Reference" code (which is in the letter of acknowledgement sent by the publisher on receipt of the
accepted article) and the name of the corresponding author. In case of problems or questions, authors may contact the Author Service
Department, E-mail: authorsupport@elsevier.com.
Proofs
When your manuscript is received at the Publisher
it is considered to be in its final form. Proofs are not to be regarded as 'drafts'.
One set of page proofs in PDF format will be
sent by e-mail to the corresponding author, to be checked for typesetting/editing. No changes in, or additions to, the accepted (and
subsequently edited) manuscript will be allowed at this stage. Proofreading is solely your responsibility.
A form with queries from
the copy editor may accompany your proofs. Please answer all queries and make any corrections or additions required.
The Publisher
reserves the right to proceed with publication if corrections are not communicated. Return corrections within two working days of receipt
of the proofs. Should there be no corrections, please confirm this.
Elsevier will do everything possible to get your article corrected
and published as quickly and accurately as possible. In order to do this we need your help. When you receive the (PDF) proof of your
article for correction, it is important to ensure that all of your corrections are sent back to us in one communication. Subsequent corrections
will not be possible, so please ensure your first sending is complete. Note that this does not mean you have any less time to make your
corrections, just that only one set of corrections will be accepted.
Offprints
1. Twenty-five offprints for regular papers
will be supplied free of charge.
2. Additional offprints can be ordered on an offprint order form, which is included with the proofs.
3. UNESCO coupons are acceptable in payment of extra offprints.
